Helus Pharma Inc. (HELP) Executive Compensation
Helus Pharma Inc. (HELP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HELP
CIK: 1833141
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 03/31
State: A1
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Zeifmans LLP
Auditor SinceSince 3/31/2022 12:00:00 AM
Lead Engagement PartnerLaurence Zeifman
Audit LocationToronto, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-15 | 2026-10-15 | 6-K | 0001833141-26-000091 | View SEC Doc Filr Page |
| 6-K | 2026-10-08 | 2026-10-08 | 6-K | 0001833141-26-000089 | View SEC Doc Filr Page |
| 6-K | 2026-10-05 | 2026-10-01 | FORM 6-K | 0001062993-26-005176 | View SEC Doc Filr Page |
| 6-K | 2026-10-02 | 2026-10-01 | 6-K | 0001833141-26-000087 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | FORM 4 | 0000912282-26-001335 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | FORM 4 | 0000912282-26-001334 | View SEC Doc Filr Page |
| 3 | 2026-10-01 | 2026-09-29 | FORM 3 | 0000912282-26-001333 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-30 | FORM 4 | 0000912282-26-001332 | View SEC Doc Filr Page |
| 6-K | 2026-10-01 | 2026-10-01 | 6-K | 0001833141-26-000084 | View SEC Doc Filr Page |
| 6-K | 2026-09-23 | 2026-09-22 | 6-K | 0001833141-26-000081 | View SEC Doc Filr Page |
| 6-K | 2026-09-22 | 2026-09-21 | 6-K | 0001833141-26-000078 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-21 | FORM 4 | 0000912282-26-001293 | View SEC Doc Filr Page |
| 6-K | 2026-09-21 | 2026-09-21 | 6-K | 0001833141-26-000076 | View SEC Doc Filr Page |
| 3 | 2026-09-17 | 2026-09-17 | FORM 3 | 0000912282-26-001277 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-08 | FORM 4 | 0000912282-26-001264 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-08 | FORM 4 | 0000912282-26-001263 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-08 | FORM 4 | 0000912282-26-001261 | View SEC Doc Filr Page |
| 6-K | 2026-09-10 | 2026-09-10 | 6-K | 0001833141-26-000074 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-04 | FORM 4 | 0000912282-26-001257 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-03 | FORM 4 | 0000912282-26-001256 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-09 | — | SCHEDULE 13D Filing | 0000912282-26-001255 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-01 | FORM 4 | 0000912282-26-001254 | View SEC Doc Filr Page |
| 3 | 2026-09-09 | 2026-09-01 | FORM 3 | 0000912282-26-001253 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | 6-K | 0001833141-26-000072 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-09 | — | SCHEDULE 13D Filing | 0000912282-26-001247 | View SEC Doc Filr Page |